Table 6.
Comparison of subjects by probiotic supplement type (n = 169; N = 763,288).
| Lact (N = 307,565) | Combo (N = 337,775) | Other/Bifi (N = 117,949) | p-value | |
|---|---|---|---|---|
| Outcomes | ||||
| A1c (%) | 6.0 ± 0.9 | 5.8 ± 0.7 | 6.1 ± 0.9 | 0.38 |
| HDL-C (mg/dL) | 55 ± 19 | 57 ± 17 | 48 ± 9 | 0.01 |
| LDL-C (mg/dL) | 99 ± 46 | 94 ± 31 | 90 ± 25 | 0.78 |
| Total cholesterol (mg/dL) | 190 ± 55 | 183 ± 36 | 178 ± 43 | 0.74 |
| Triglyceride level (mg/dL) | 122 ± 57 | 133 ± 86 | 137 ± 57 | 0.60 |
| ASCVD risk score (%) | 18 ± 15 | 17 ± 15 | 21 ± 15 | 0.89 |
| Blood pressure (systolic) (mmHg) | 130 ± 21 | 133 ± 20 | 135 ± 24 | 0.88 |
| Blood pressure (diastolic) (mmHg) | 70 ± 10 | 73 ± 12 | 61 ± 14 | 0.01 |
| BMI (kg/m2) | 31 ± 8 | 32 ± 7 | 31 ± 8 | 0.94 |
| Demographics | ||||
| Age (years) | 63.9 ± 12 | 66.7 ± 9.3 | 63.6 ± 14.5 | 0.24 |
| Sex | 0.06 | |||
| Male | 35.4% | 35.0% | 68.1% | |
| Female | 64.6% | 65.0% | 31.9% | |
| Race/Ethnicity | 0.01 | |||
| NHW | 89.0% | 83.4% | 61.7% | |
| NHB | 6.7% | 6.0% | 10.6% | |
| NHO | 2.3% | 1.6% | 15.1% | |
| Hispanic | 2.1% | 9.0% | 12.5% | |
| Marital status | 0.80 | |||
| Married/Partner | 67.3% | 61.9% | 69.3% | |
| Not married | 32.7% | 38.1% | 30.7% | |
| Ratio of family income to poverty | 3.2 ± 1.5 | 3.8 ± 1.49 | 2.7 ± 1.5 | 0.07 |
| Education level | 0.45 | |||
| < HS | 12.5% | 7.1% | 3.9% | |
| HS | 21.6% | 15.6% | 10.1% | |
| College+ | 65.8% | 77.3% | 86.1% | |
| MET score | 839.6 ± 756.7 | 787.3 ± 1,009.0 | 804.6 ± 958.2 | 0.95 |
| MET score (Categorical) | 0.41 | |||
| Low | 33.2% | 30.5% | 35.1% | |
| Medium | 33.6% | 52.2% | 26.6% | |
| High | 33.1% | 17.2% | 38.3% | |
HDL-C, High-density lipoprotein cholesterol; LDL-C, Low-density lipoprotein cholesterol; ASCVD, Atherosclerotic cardiovascular disease; BMI, Body mass index; MET, Metabolic equivalent task. Bold formatting indicates p-values of statistical significance.